New tool aims to boost HIV prevention in Women's health clinics

NCT ID NCT06684613

Recruiting now Prevention Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a decision aid that helps women in sexual and reproductive health clinics decide whether to take PrEP, a daily pill that prevents HIV. The tool will be used during counseling visits. Researchers will see if it increases PrEP use and if it's practical for clinics. The study involves 50 women who do not have HIV and are not currently on PrEP.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PrEP Decision Aid (device)
What this could lead to: If successful, this tool could help more women at risk of HIV get the prevention they need during routine clinic visits.
What could go wrong: This is a small, early feasibility study with only 50 participants, so results may not apply broadly. The decision aid may not change behavior or be adopted widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REPRODUCTIVE HEALTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

REPRODUCTIVE HEALTH SEXUAL RISK BEHAVIOR FOR HIV-INFECTION

Contacts and locations

Locations

Yale Clinical and Community Research
RECRUITING

New Haven, Connecticut, 06519, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.